Cellular Immunotherapy and Cancer

Seminars in Oncology

Volumn 31, Issue 2 SUPPL. 4, 2004, Pages 87-90

  Waller, Edmund K ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; TUMOR ANTIGEN;

ADOPTIVE IMMUNOTHERAPY; ALLOTRANSPLANTATION; ANTIGEN RECOGNITION; ANTINEOPLASTIC ACTIVITY; CANCER; CANCER IMMUNOTHERAPY; CELL ACTIVATION; CELLULAR IMMUNITY; CONFERENCE PAPER; DENDRITIC CELL; GRAFT VERSUS LEUKEMIA EFFECT; HUMAN; IMMUNE DEFICIENCY; IMMUNE RESPONSE; NATURAL KILLER CELL; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL;

EID: 2342664929     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminoncol.2004.02.021     Document Type: Conference Paper

References (23)

1. Diefenbach A, Raulet DH: The innate immune response to tumors and its role in the induction of T-cell immunity. Immunol Rev 188:9-21, 2002
2. Ruggeri L, Capanni M, Tosti A, et al: Innate immunity against hematological malignancies. Cytotherapy 4:343-346, 2002
3. Smyth MJ, Godfrey DI, Trapani JA: A fresh look at tumor immunosurveillance and immunotherapy. Nat Immunol 2:293-299, 2001
4. van Besien K, Sobocinski KA, Rowlings PA, et al: Allogeneic bone marrow transplantation for low-grade lymphoma. Blood 95:1832-1836, 1998
5. Levine JE, Harris RE, Loberiza FR, et al: A comparison of allogeneic and autologous bone marrow transplantation for lymphoblastic lymphoma. Blood 101:2476-2482, 2003
6. Zittoun RA, Mandelli F, Willemze R, et al: Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) Leukemia Cooperative Groups. N Engl J Med 332:217-223, 1995
7. Horowitz MM, Gale RP, Sondel PM, et al: Graft-versus-leukemia reactions after bone marrow transplantation. Blood 75:555-562, 1990
8. Gale RP, Horowitz MM: Graft-versus-leukemia in bone marrow transplantation. The Advisory Committee of the International Bone Marrow Transplant Registry. Bone Marrow Transplant 6:94-97, 1990
9. Mackinnon S: Donor leukocyte infusions for relapsed leukemia after allogeneic BMT. Hematol Cell Ther 38:461-462, 1996
10. Ruggeri L, Capanni M, Urbani E, et al: Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 295:2097-2100, 2002
11. Wagner JE, Rosenthal J, Sweetman R, et al: Successful transplantation of HLA-matched and HLA-mismatched umbilical cord blood from unrelated donors: Analysis of engraftment and acute graft-versus-host disease. Blood 88:795-802, 1996
12. Rocha V, Cornish J, Sievers EL, et al: Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia. Blood 97:2962-2971, 2001
13. Wagner JE, Barker JN, DeFor TE, et al: Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood 100:1611-1618, 2002
14. Redei I, Langston AA, Lonial S, et al: Rapid hematopoietic engraftment following fractionated TBI conditioning and transplantation with CD34(+) enriched hematopoietic progenitor cells from partially mismatched related donors. Bone Marrow Transplant 30:335-340, 2002
15. Aversa F, Tabilio A, Terenzi A, et al: Successful engraftment of T-cell-depleted haploidentical "three-loci" incompatible transplants in leukemia patients by addition of recombinant human granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells to bone marrow inoculum. Blood 84:3948-3955, 1994
16. Aversa F, Tabilo A, Velardi A, et al: Treatment of high-risk acute leukemia with T-cell depleted stem cells from related donors with one fully mismatched HLA haplotype. N Engl J Med 339:1186-1193, 1998
17. Waller EK, Langston A, Lonial S, et al: Pharmacokinetics and pharmacodynamics of anti-thymocyte globulin in recipients of partially HLA-matched blood hematopoietic progenitor cell transplantation. Biol Blood Marrow Transplant 9:460-471, 2003
18. Langston AA, Redei I, Caliendo AM, et al: Development of drug-resistant herpes simplex virus infection after haploidentical hematopoietic progenitor cell transplantation. Blood 99:1085-1088, 2002
19. Waller EK, Rosenthal H, Jones TW, et al: Larger numbers of CD4(bright) dendritic cells in donor bone marrow are associated with increased relapse after allogeneic bone marrow transplantation [erratum appears in Blood 98:1677, 2001]. Blood 97:2948-2956, 2001
20. Waller EK, Rosenthal H, Jones TW, et al: Larger numbers of CD4(bright) dendritic cells in donor bone marrow are associated with increased relapse after allogeneic bone marrow transplantation [erratum appears in Blood 98:1677, 2001]. Blood 97:2948-2956, 2001
21. Arpinati M, Green CL, Heimfeld S, et al: Granulocyte-colony stimulating factor mobilizes T helper 2-inducing dendritic cells. Blood 95:2484-2490, 2000
22. Shlomchik WD, Couzens MS, Tang CB, et al: Prevention of graft versus host disease by inactivation of host antigen-presenting cells. Science 285:412-415, 1999
23. Steinman RM, Turley S, Mellman I, et al: The induction of tolerance by dendritic cells that have captured apoptotic cells. J Exp Med 191:411-416, 2000